NCT03289481View on ClinicalTrials.gov

Treatment of HFpEF With Nitrate Supplement

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

August 22, 2018

Study Completion Date

August 22, 2018

Conditions
Heart Failure With Normal Ejection Fraction
Interventions
DIETARY_SUPPLEMENT

Active lozenge

nitric oxide generating lozenge

DRUG

Placebo

placebo tablet

Trial Locations (1)

04856

Penobscot Bay Medical Center, Rockport

Sponsors

Lead Sponsor

MaineHealth

Collaborators (1)

HumanN
All Listed Sponsors
collaborator

HumanN

INDUSTRY

lead

MaineHealth

OTHER

NCT03289481 - Treatment of HFpEF With Nitrate Supplement | Biotech Hunter | Biotech Hunter